Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
59.74
+2.96 (5.21%)
At close: Jun 26, 2026, 4:00 PM EDT
60.10
+0.36 (0.60%)
After-hours: Jun 26, 2026, 4:54 PM EDT
Xenon Pharmaceuticals Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for Xenon Pharmaceuticals stock have an average target of 78.48, with a low estimate of 55 and a high estimate of 100. The average target predicts an increase of 31.37% from the current stock price of 59.74.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Xenon Pharmaceuticals stock from 20 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 18 | 17 | 17 | 17 | 17 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 21 | 20 | 20 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $69 | Buy | Maintains | $69 | +15.50% | Jun 2, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $80 → $82 | Buy | Reiterates | $80 → $82 | +37.26% | May 27, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $55 → $80 | Buy | Maintains | $55 → $80 | +33.91% | May 8, 2026 |
| Wedbush | Wedbush | Buy Maintains $63 | Buy | Maintains | $63 | +5.46% | May 8, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $80 → $82 | Buy | Maintains | $80 → $82 | +37.26% | May 8, 2026 |
Financial Forecast
Revenue This Year
2.07M
from 7.50M
Decreased by -72.46%
Revenue Next Year
35.17M
from 2.07M
Increased by 1,602.70%
EPS This Year
-4.81
from -4.36
EPS Next Year
-5.01
from -4.81
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 22.6M | 175.0M | |
| Avg | 2.1M | 35.2M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 201.5% | 8,370.8% | |
| Avg | -72.5% | 1,602.7% | |
| Low | -100.0% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -4.81 | -5.01 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.